大正製薬ホールディングス(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証STD医薬品4581/E25678-
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2022/04/01日証協無担保0株0%0株0%16,697株+5465.67%
2022/04/01日証協有担保309,158株-37.44%22,373株-16.27%175,655株+121.43%
2022/03/25日証協無担保0株-100%0株0%300株-93.33%
2022/03/25日証協有担保494,174株+51.6%26,722株-77.75%79,327株-36.09%
2022/03/18日証協無担保16,006株0%0株0%4,500株+638.92%
2022/03/18日証協有担保325,966株-19.4%120,083株+18.1%124,118株-46.81%
2022/03/11日証協無担保0株0%0株0%609株+0.16%
2022/03/11日証協有担保404,421株-0.18%101,681株+424.05%233,353株+101.71%
2022/03/04日証協無担保0株0%0株0%608株-82.12%
2022/03/04日証協有担保405,156株-2.38%19,403株-39.54%115,689株-5.24%
2022/02/25日証協無担保0株0%0株-100%3,400株-79.51%
2022/02/25日証協有担保415,013株-14.83%32,093株-36.07%122,088株+92.53%
2022/02/18日証協無担保0株0%4,810株0%16,591株+9999.99%
2022/02/18日証協有担保487,261株+11.11%50,199株+192.28%63,411株-31.75%
2022/02/10日証協無担保0株-100%0株-100%2株-99.98%
2022/02/10日証協有担保438,550株-30.69%17,175株-72.86%92,910株-60.75%
2022/02/04日証協無担保5,976株0%2,210株0%12,302株+146.04%
2022/02/04日証協有担保632,711株+68.78%63,275株+13.8%236,737株+137.66%
2022/01/28日証協無担保0株0%0株0%5,000株+31.48%
2022/01/28日証協有担保374,865株-64.1%55,604株-25.58%99,613株-49.01%
2022/01/21日証協無担保0株0%0株0%3,803株+30.96%
2022/01/21日証協有担保1,044,101株+58.12%74,720株-0.9%195,363株-4.23%
2022/01/14日証協無担保0株-100%0株0%2,904株-40.86%
2022/01/14日証協有担保660,324株-27.82%75,395株+1277.08%204,000株-20.6%
2022/01/07日証協無担保5,056株+125.71%0株0%4,910株-56.99%
2022/01/07日証協有担保914,815株+121.61%5,475株-93.55%256,920株+135.71%
2021/12/30日証協無担保2,240株0%0株0%11,415株0%
2021/12/30日証協有担保412,811株0%84,890株0%108,999株0%
2021/12/24日証協無担保2,240株-99.19%0株0%11,415株-82.41%
2021/12/24日証協有担保412,811株-39.28%84,890株+1061.29%108,999株-69.51%
2021/12/17日証協無担保276,700株+6643.85%0株0%64,901株+5800.09%
2021/12/17日証協有担保679,878株+114.71%7,310株-77.57%357,519株+153.79%
2021/12/10日証協無担保4,103株-70.83%0株0%1,100株+4.46%
2021/12/10日証協有担保316,651株-33.56%32,585株-59.02%140,873株-25.56%
2021/12/03日証協無担保14,064株0%0株0%1,053株+75.5%
2021/12/03日証協有担保476,609株+120.01%79,515株+758.51%189,252株+242.85%
2021/11/26日証協無担保0株-100%0株0%600株-47.83%
2021/11/26日証協有担保216,631株-0.12%9,262株-85.19%55,200株-42.57%

※株式分割は考慮していませんのでご注意ください。

Page Top